Castle Biosciences, Inc. Share Price
Stocks
CSTL
US14843C1053
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
21:00:00 11/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 33.99 USD | -1.25% |
|
-4.92% | -12.62% |
| Market Cap | 1.05B 944M 872M 789M 1.49B 98.25B 1.53B 10.45B 4.17B 52.62B 3.93B 3.85B 167B | P/E 2026 * |
-40.1x | P/E 2027 * | -49.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.05B 944M 872M 789M 1.49B 98.25B 1.53B 10.45B 4.17B 52.62B 3.93B 3.85B 167B | EV / Sales 2026 * |
2.67x | EV / Sales 2027 * | 2.41x |
| Free-Float |
97.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| CSTL | Delayed | |
CBOE
| CSTL | Real-time | |
|
Tradegate
| 086 | Real-time | |
|
Deutsche Boerse AG
| 086 | Delayed | |
|
Deutsche Boerse AG
| 086 | End-of-day quote |
Last Transcript: Castle Biosciences, Inc.
| 1 day | -1.25% | ||
| 1 week | -4.92% | ||
| Current month | -8.53% | ||
| 1 month | -1.25% | ||
| 3 months | +5.43% | ||
| 6 months | +78.52% | ||
| Current year | -12.62% |
| 1 week | 31.81 |  | 36 |
| 1 month | 31.67 | | 38.72 |
| Current year | 17.72 | | 44.28 |
| 1 year | 17.72 | | 44.28 |
| 3 years | 14.59 | | 44.28 |
| 5 years | 9.26 | | 54.62 |
| 10 years | 9.26 | | 107.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
CEO | Chief Executive Officer | 64 | 31/08/2007 |
Franklin Stokes
DFI | Director of Finance/CFO | 56 | 30/11/2017 |
Johnson Clare
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Derek Maetzold
BRD | Director/Board Member | 64 | 31/08/2007 |
Daniel Bradbury
CHM | Chairman | 64 | 31/08/2014 |
G. Cole
BRD | Director/Board Member | 70 | 05/12/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 02/11/26 | Sell | Chief Executive Officer | -14,496 | 0.0475% | ||
| 28/10/26 | Sell | Executive/Senior Manager | -6,578 | 0.0215% | ||
| 26/10/26 | Sell | Executive/Senior Manager | -3,288 | 0.0108% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.25% | -4.92% | -2.80% | +97.85% | 1.05B | |
| -1.06% | -5.38% | -13.94% | +16.30% | 189B | |
| +0.02% | -3.19% | +6.51% | +43.76% | 124B | |
| -1.70% | -6.14% | -12.35% | +16.51% | 121B | |
| -0.77% | -5.50% | -43.44% | +2.63% | 93.09B | |
| +0.34% | -1.16% | -4.16% | +77.09% | 66.77B | |
| +0.90% | +2.55% | +13.49% | -8.58% | 58.43B | |
| +0.85% | +0.58% | -1.39% | +63.88% | 55.35B | |
| +0.96% | +0.06% | -1.73% | +56.33% | 49.49B | |
| +2.14% | -3.31% | -5.25% | -7.50% | 34.53B | |
| Average | -0.01% | -2.58% | -6.51% | +35.83% | 79B | |
| Weighted average by Cap. | -0.32% | -3.11% | -9.08% | +27.20% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 392M 354M 327M 295M 559M 36.79B 572M 3.91B 1.56B 19.7B 1.47B 1.44B 62.71B | 434M 391M 361M 327M 618M 40.71B 633M 4.33B 1.73B 21.8B 1.63B 1.59B 69.38B |
| Net income | -26.3M -23.7M -21.9M -19.79M -37.45M -2.47B -38.37M -262M -105M -1.32B -98.69M -96.59M -4.2B | -24.11M -21.73M -20.07M -18.15M -34.33M -2.26B -35.18M -241M -95.89M -1.21B -90.48M -88.55M -3.85B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/11/26 | US$33.99 | -1.25% | 335,311 |
| 10/11/26 | US$34.42 | +0.12% | 407,939 |
| 09/11/26 | US$34.38 | +5.72% | 563,385 |
| 06/11/26 | US$32.52 | -4.91% | 981,764 |
| 05/11/26 | US$34.20 | -4.34% | 701,872 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CSTL Stock
Select your edition
All financial news and data tailored to specific country editions
